1,2-Dichloroethane → 2-(t-Butyloxycarbonyl)-1,2,3,4-tetrahydro-isoquinoline-3(S)-carboxylic acid {2-[3-(4-cyanobenzyl)-3H-imidazol-4-yl]-ethyl}-amide
反応式
[C:1]([O:5][C:6]([N:8]1[C@H:17]([C:18]([OH:20])=O)[CH2:16][C:15]2[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=2)[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[C:21]([C:23]1[CH:37]=[CH:36][C:26]([CH2:27][N:28]2[C:32]([CH2:33][CH2:34][NH2:35])=[CH:31][N:30]=[CH:29]2)=[CH:25][CH:24]=1)#[N:22].ON1C2C=CC=CC=2N=N1.C(Cl)CCl.CN1CCOCC1>CN(C=O)C>[C:21]([C:23]1[CH:37]=[CH:36][C:26]([CH2:27][N:28]2[C:32]([CH2:33][CH2:34][NH:35][C:18]([C@@H:17]3[CH2:16][C:15]4[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=4)[CH2:9][N:8]3[C:6]([O:5][C:1]([CH3:3])([CH3:2])[CH3:4])=[O:7])=[O:20])=[CH:31][N:30]=[CH:29]2)=[CH:25][CH:24]=1)#[N:22]参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of 2-(t-butyloxycarbonyl)-1,2,3,4-tetrahydro-isoquinoline-3(S)-carboxylic acid (0.15 g, 0.54 mmol) and 3-(4-cyanobenzyl) histamine (0.122 g, 0.54 mmol) in DMF (5 mL) was added 1-hydroxybenzotriazole (0.083 g, 0.54 mmol), EDC (0.104 g, 0.54 mmol), and N-methylmorpholine (0.24 mL, 2.16 mmol). After stirring for 18 hr. the mixture was evaporated in vacuo and the residue was partitioned with EtOAc (50 mL) and saturated NaHCO3 (30 mL). The organic layer was washed with saturated NaCl solution (30 mL) and dried (MgSO4). Filtration was done which gave the title compound.
後処理
- customthe mixture was evaporated in vacuo
- customthe residue was partitioned with EtOAc (50 mL) and saturated NaHCO3 (30 mL)
- washThe organic layer was washed with saturated NaCl solution (30 mL)
- dry with materialdried (MgSO4)
- filtrationFiltration
出典と根拠
- ORDレコード
- ord-1390598413ab4267aa2f06fbc05b6cd4
- 出典データセット
- uspto-grants-1999_08
- 特許番号
- US05932590
反応ノート
読み込み中…